检索结果 - Kyung-Hun Lee

Refine Results
  1. 1
    Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions

    Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions 由 Dae‐Won Lee, Kyung-Hun Lee, Jin Ho Kim, Bhumsuk Keam

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Major clinical research advances in gynecologic cancer in 2018

    Major clinical research advances in gynecologic cancer in 2018 由 Miseon Kim, Dong Hoon Suh, Kyung-Hun Lee, Keun‐Yong Eom, Nanna Gilliam Toftdahl, Mansoor Raza Mirza, Jae‐Weon Kim

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index

    Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index 由 Younak Choi, Do‐Youn Oh, Tae‐Yong Kim, Kyung-Hun Lee, Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Yung‐Jue Bang

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy

    The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy 由 Younak Choi, Tae-Yong Kim, Do‐Youn Oh, Kyung-Hun Lee, Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Yung‐Jue Bang

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma

    Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma 由 Changhoon Yoo, JiHoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung Ah Lee, Kyung-Hun Lee, Tae‐You Kim, Baek‐Yeol Ryoo

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer

    Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer 由 Chan‐Young Ock, Do‐Youn Oh, Joongyub Lee, Tae‐Yong Kim, Kyung-Hun Lee, Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Yung‐Jue Bang

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer

    Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract... 由 Kyoung-Min Cho, Hyunkyung Park, Do‐Youn Oh, Tae‐Yong Kim, Kyung-Hun Lee, Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Yung‐Jue Bang

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer

    Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer 由 Dong-Hyeon Ha, Ahrum Min, Seongyeong Kim, Hyemin Jang, So Hyeon Kim, Hee Jun Kim, Han Suk Ryu, Ja‐Lok Ku, Kyung-Hun Lee, Seock‐Ah Im

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology

    The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology 由 Kelly A. Hirko, Gabrielle B. Rocque, Erica Reasor, Ammanuel Taye, Alex Daly, Ramsey Cutress, Ellen Copson, Dae‐Won Lee, Kyung-Hun Lee, Seock‐Ah Im, Yeon Hee Park

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Prognostic implication of antitumor immunity measured by the neutrophil–lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer

    Prognostic implication of antitumor immunity measured by the neutrophil–lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer 由 Chan-Young Ock, Ah-Rong Nam, Joongyub Lee, Ju-Hee Bang, Kyung-Hun Lee, Sae‐Won Han, Tae Yong Kim, Seock‐Ah Im, Tae-You Kim, Yung‐Jue Bang, Do‐Youn Oh

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

    Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy 由 Hyerim Ha, Ah‐Rong Nam, Ju‐Hee Bang, Ji‐Eun Park, Tae‐Yong Kim, Kyung-Hun Lee, Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Yung‐Jue Bang, Do‐Youn Oh

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial

    Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial 由 Masatoshi Kudo, Ho Yeong Lim, Ann‐Lii Cheng, Yee Chao, Thomas Yau, Sadahisa Ogasawara, Masayuki Kurosaki, Naoki Morimoto, Kazuyoshi Ohkawa, Tatsuya Yamashita, Kyung-Hun Lee, Erluo Chen, Abby B. Siegel, Baek‐Yeol Ryoo

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

    Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative... 由 Ahrum Min, Seock‐Ah Im, Debora Keunyoung Kim, Sang-Hyun Song, Hee Jun Kim, Kyung-Hun Lee, Tae‐Yong Kim, Sae‐Won Han, Do‐Youn Oh, Tae‐You Kim, Mark J. O’Connor, Yung‐Jue Bang

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

    Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer 由 Chan-Young Ock, Keun‐Wook Lee, Jin Won Kim, Jin-Soo Kim, Tae‐Yong Kim, Kyung-Hun Lee, Sae‐Won Han, Seock‐Ah Im, Tae-You Kim, Woo Ho Kim, Yung‐Jue Bang, Do‐Youn Oh

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

    Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphoryla... 由 Sae‐Won Han, Tae‐You Kim, Yoon Kyung Jeon, Pil Gyu Hwang, Seock‐Ah Im, Kyung-Hun Lee, Jee Hyun Kim, Dong‐Wan Kim, Dae Seog Heo, Noe Kyeong Kim, Doo Hyun Chung, Yung‐Jue Bang

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

    Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy 由 Kyung-Hun Lee, Seock‐Ah Im, Do‐Youn Oh, Se‐Hoon Lee, Eui Kyu Chie, Wonshik Han, Dong-Wan Kim, Tae‐You Kim, In Ae Park, Dong‐Young Noh, Dae Seog Heo, Sung Whan Ha, Yung‐Jue Bang

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

    Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment 由 Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Tae‐You Kim, Yoon Jun Kim

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    <i><scp>ABCB</scp>1</i> polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy

    <i><scp>ABCB</scp>1</i> polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy 由 Hee‐Jun Kim, Seock‐Ah Im, Bhumsuk Keam, Hye Seon Ham, Kyung Hun Lee, Tae Yong Kim, Yu Jung Kim, Do‐Youn Oh, Jee Hyun Kim, Wonshik Han, In‐Jin Jang, Tae‐You Kim, In Ae Park, Dong‐Young Noh

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

    Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis 由 Bhumsuk Keam, Seock‐Ah Im, Kyung-Hun Lee, Sae‐Won Han, Do‐Youn Oh, Jee Hyun Kim, Se‐Hoon Lee, Wonshik Han, Dong-Wan Kim, Tae‐You Kim, In Ae Park, Dong‐Young Noh, Dae Seog Heo, Yung‐Jue Bang

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells

    Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells 由 Hee‐Jun Kim, Ahrum Min, Seock‐Ah Im, Hyemin Jang, Kyung Hun Lee, Alan Lau, Miso Lee, Seongyeong Kim, Yaewon Yang, Jung‐Eun Kim, Tae Yong Kim, Do‐Youn Oh, Jeffrey S. Brown, Mark J. O’Connor, Yung‐Jue Bang

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: